Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 6,429 | 3,912 | 663 | 605 | 2,863 |
| Operating Income | -6,429 | -3,912 | -663 | -605 | -2,863 |
| Other Income | -1,173 | 4,436 | 1 | 1 | 2 |
| Pre-tax Income | -7,602 | 524 | -662 | -604 | -2,861 |
| Net Income Continuous | -7,602 | 524 | -662 | -604 | -2,861 |
| Minority Interests | -66 | N/A | N/A | N/A | N/A |
| Net Income | $-7,536 | $575 | $-662 | $-604 | $-2,861 |
| EPS Basic Total Ops | -101.57 | 96.24 | -33.83 | -30.83 | -154.14 |
| EPS Basic Continuous Ops | -102.73 | 95.04 | -33.95 | -31.08 | -153.98 |
| EPS Diluted Total Ops | -101.57 | 96.24 | -33.83 | -30.83 | -154.14 |
| EPS Diluted Continuous Ops | -102.73 | 95.04 | -33.95 | -31.08 | -153.98 |
| EBITDA(a) | $-6,429 | $-3,912 | $-663 | $-605 | $-2,863 |